The independent pro-carcinogenic mechanism and therapeutic potential of RNA interference established by ZKSCAN3 in bladder cancer provide an important basis for exploring its interaction with other oncogenic signaling pathways. This evidence concerns the gene ZKSCAN3 and urinary bladder cancer.